in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—29 July 2014
1:30 AM MDT | July 29, 2014 | Deepti Ramesh
Lonza reports huge rise in profits Lonza recorded net profits of 140 million Swiss francs ($155 million) for the first half of 2014 compared with profits of SF41 million in the first half of 2013. Sales for the first half of 2014 increased by 3.2% compared with the year-ago period, to SF1.80 billion. In the first half of 2014, Lonza’s specialty ingredients and pharma and biotech market segments both delivered a sound performance despite currency headwinds and are fully on track to deliver the growth targets, Lonza says. The sales growth of 3.2% and core...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee